$604 Million is the total value of BROADWOOD CAPITAL INC's 7 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 12.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNST | MONSTER BEVERAGE CORP NEW | $265,057,000 | +11.2% | 4,797,408 | 0.0% | 43.90% | +0.2% | |
| STAA | STAAR SURGICAL CO | $135,147,000 | +15.3% | 10,855,179 | 0.0% | 22.38% | +3.8% | |
| BTX | Buy | BIOTIME INC | $77,473,000 | -9.3% | 27,279,254 | +0.6% | 12.83% | -18.3% |
| IWM | ISHARES TRrussell 2000 etf | $62,236,000 | +5.2% | 420,000 | 0.0% | 10.31% | -5.3% | |
| OCX | Buy | ONCOCYTE CORPORATION | $27,155,000 | +70.8% | 3,596,680 | +17.7% | 4.50% | +53.9% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $24,097,000 | +66.8% | 644,822 | +100.0% | 3.99% | +50.2% |
| AST | ASTERIAS BIOTHERAPEUTICS INC | $12,579,000 | -4.2% | 3,699,848 | 0.0% | 2.08% | -13.7% | |
| ASTWS | Exit | ASTERIAS BIOTHERAPEUTICS INC*w exp 09/29/201 | $0 | – | -328,205 | -100.0% | -0.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STAAR SURGICAL CO | 42 | Q3 2023 | 59.1% |
| MONSTER BEVERAGE CORP NEW | 34 | Q3 2023 | 49.7% |
| ISHARES TR | 33 | Q3 2023 | 14.8% |
| ONCOCYTE CORPORATION | 31 | Q2 2023 | 4.6% |
| BIOTIME INC | 25 | Q2 2019 | 17.8% |
| AXON ENTERPRISE INC | 24 | Q3 2023 | 13.4% |
| AGEX THERAPEUTICS INC | 20 | Q3 2023 | 1.5% |
| LINEAGE CELL THERAPEUTICS INC | 17 | Q3 2023 | 5.1% |
| ASTERIAS BIOTHERAPEUTICS INC | 16 | Q4 2018 | 2.9% |
| CYNOSURE INC | 15 | Q4 2016 | 10.4% |
View BROADWOOD CAPITAL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 4 | 2024-01-10 |
| 4 | 2024-01-05 |
| 4 | 2023-11-30 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-11-14 |
| 4 | 2023-11-09 |
| 4 | 2023-11-06 |
View BROADWOOD CAPITAL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.